01
Low NADAC$0.139
→
Avg plan cost$1.21
Part D spend $101.8M
9× spread, current vs floor
Drug class profile · refreshed daily from federal data
Immunosuppressant
1 molecule in this class, $101.8M combined CY2024 Part D spend across 788K claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily
Class summary at a glance.
Every drug in the Immunosuppressant class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $101.8Mcombined across class
- Total Rx claims
- 788K217K unique beneficiaries
- Generic mfrs (active)
- 24across all molecules